Clinical Trial Update: Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC [NA]

View source ↗

Summary

This entry describes an ongoing clinical trial investigating dose de-escalation and sentinel lymph node mapping-guided radiotherapy for ipsilateral node-positiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Squamous Cell Carcinoma of Head and Neck | NA | Status: RECRUITING